A quantitative characterization of the heterogeneous response of glioblastoma U-87 MG cell line to temozolomide
Abstract Most cancers are genetically and phenotypically heterogeneous. This includes subpopulations of cells with different levels of sensitivity to chemotherapy, which may lead to treatment failure as the more resistant cells can survive drug treatment and continue to proliferate. While the geneti...
Saved in:
| Main Authors: | Pragyesh Dixit, Ilyas Djafer-Cherif, Saumil Shah, Karolina Drabik, Arne Traulsen, Bartlomiej Waclaw |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-99426-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01) -
Synergistic effect of perampanel with temozolomide on glioblastoma cells in vivo
by: Takuma Nishide, et al.
Published: (2025-03-01) -
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
by: Justyna Magdalena Przystal, et al.
Published: (2019-02-01) -
Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells
by: Samantha L. Gerlach, et al.
Published: (2024-09-01) -
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
by: Emil Lou, et al.
Published: (2013-04-01)